jeffrey cohen, md: ofatumumab’s potential role in ms care
Published 4 years ago • 984 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
2:26
jeffrey cohen, md: the success of ofatumumab in relapsing ms
-
3:08
jeffrey cohen, md: s1p modulator development in multiple sclerosis
-
1:31
jeffrey cohen, md: challenges to be addressed in the ms space
-
2:24
jeffrey cohen, md: the advantages of more selective s1p modulators
-
4:33
drugs in development for ms, including ofatumumab
-
3:41
jeffrey cohen, md, on new ms criteria
-
4:41
ofatumumab for relapsing ms
-
1:01
unmet needs in multiple sclerosis
-
3:41
stephen l. hauser, md: ofatumumab in treatment-naïve patients with ms
-
33:47
episode 168: remyelination in ms with dr. jeffrey cohen & dr. ian duncan
-
32:35
episode 215: stem cell therapy for ms with dr. jeffrey cohen
-
2:23
stephen l. hauser, md: increasing understanding of disease progression in ms
-
1:13
how to approach ms treatment sequencing in a crowded therapeutic market
-
1:21
dr. friedman on the future of selinexor in multiple myeloma
-
0:22
how many people have ms?
-
2:33
predicting benign disease course in ms
-
4:35
ectrims 2017 – jeffrey cohen interview
-
2:03
dr. michael s. jaffee, md uf health neurologist
-
1:35
actrims research priorities